|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| PHARMACEUTICAL EXECUTIVE FORUM | ||||||||||||||||
| July 26, 2001 | ||||||||||||||||
|
Cambridge Heathtech Institute, Hamilton, Bermuda November 7-9, 2001 The conference has been formatted to encourage optimal participation and interaction by the audience. Each session includes provocative presentations by acknowledged industry thought leaders. The use of case studies and workshops is employed for several topics, to increase interactivity. When appropriate, some sessions include a perspective from outside the life sciences, to facilitate thinking outside the box and learning from other industries that have faced similar challenges. Each session allows time for Q&A from the audience. Additional time is provided every day for private discussion among attendees and presenters, as well as relaxation, social activities, and sports. To create maximum interaction among participants, all sessions will be closed to the media and all discussions will be confidential. |
||||||||||||||||
| Organized by: | CHI | |||||||||||||||
| Invited Speakers: | Christopher Jock, Senior Director, Kelly Scientific Joe Prochaska, President, Donlar Life Sciences Dr. Peter Barrett, Executive Vice President and Chief Business Officer, Celera Genomics Dr. Thomas McKearn, Exuctive Director, Strategic Science and Medicine, Bristol-Myers Squibb Dr. Aris Presidis, Managing Director, RheoGene Dr. Joe Horvath, Millennium Pharmaceuticals Patrick Chassaigne, Director, Life Science Solutions, Compaq Dr. Michael Silber, Director, Pharmacogenomics and Clinical Biochemical Measurements, Pfizer |
|||||||||||||||
| Deadline for Abstracts: | n/a | |||||||||||||||
| Registration: | *Attendance by Invitation Only Conference attendance is limited to senior executives at pharmaceutical, biopharmaceutical, and biotechnology companies, along with senior faculty, management, and executive-level personnel at major research universities, independent research institutes, and government laboratories. If you have not received a brochure directly but feel that you qualify to attend, please send in the registration form as an application to attend. |
|||||||||||||||
| E-mail: | jlaakso@healthtech.com | |||||||||||||||
| Posted by: | Jennifer Laakso | |||||||||||||||
| Host: | wks217.healthtech.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||